Single-use Bioreactors Market by Product (Single Use Bioreactor Systems, Filtration Assemblies, and Media Bags), Molecule Type(Monoclonal Antibodies (MABS), Stem Cells, and Vaccines Gene-Modified Cells), Cell Type(Mammalian Cells, Yeast Cells, and Bacterial Cells) and End User (Biotechnology Companies, and Biopharmaceutical Companies) - Analysis & Forecast 2019-2030
Report ID : 28 | Published Date : Feb 2019 | Pages : 150 | Region : global | Report Code : BT-8
Single-use Bioreactors Market Overview and Introduction
A single-use bioreactor is form of disposable reactor which utilizes disposable bags instead of culture vessels. This type of bioreactor is majorly used for culturing of mammalian cell culturing in place of alternatives, namely conventional bioreactors. The disposable bags used in single-use bioreactors are made of a three-layered plastic foil.
The global single-use bioreactors market is driven by benefits which these reactors possess as compared to its conventional counterparts, namely reduced demands for sterilization and cleaning and fewer components as compared to the prior. Moreover, several benefits associated with the use of single-use bioreactors have been crucial in supporting the growth of this market. However, recurring expenses which are needed regularly in anticipated to restrain the growth of single-use bioreactor market.
Single-use Bioreactors Market by Product, Molecule Type, Cell Type and End User
The global single-use bioreactors market is segmented by product, molecule type, cell type, end user, and region. On the basis of product, the single-use bioreactors market is segmented into single use bioreactor systems, filtration assemblies, media bags and other products. In terms of revenue, the segment of single use bioreactor systems is anticipated to account for largest market share in 2018, owing to several advantages these systems provides, namely shortened downtime, lowered risk of cross-contamination, elimination of validation issues and others. The molecule type segment can be classified into Monoclonal Antibodies (mabs), stem cells, vaccines gene-modified cells and other molecules. In 2018, the segment of Monoclonal Antibodies (MABS) is anticipated to be the major revenue generating segment owing to need for obtaining dynamic therapeutic mechanism for different forms of ailments. Based on the cell type, the market is segmented into mammalian cells, yeast cells, bacterial cells and other cells. Finally, on the basis of end user the single-use bioreactors market can be bifurcated into biotechnology companies, biopharmaceutical companies and other end users.
Single-use Bioreactors Market by Regions
The global single-use bioreactors market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). Europe dominated the market of single-use bioreactors market, followed by North America and Asia Pacific. Europe will continue to dominate the global single-use bioreactors market in the forecast period owing to factors such as increasing R&D projects, increasing adoption of latest technologies, and presence of major pharmaceutical players in the region. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as rising population, increasing adoption of latest technologies, and high market penetration have been crucial in contributing to the growth of the global single-use bioreactors market.
Single-use Bioreactors Market Prominent Players
The prominent players in the global single-use bioreactors market are Sartorius AG, Merck KGaA, General Electric Company, Thermo Fisher Scientific, Danaher, Applikon Biotechnology, Eppendorf AG, Celltainer, Pierre Guérin, and Cellexus Ltd among others.